Literature DB >> 10640726

Functional consequences of the developmental arrest and follicular exclusion of anti-double-stranded DNA B cells.

L Mandik-Nayak1, S j Seo, A Eaton-Bassiri, D Allman, R R Hardy, J Erikson.   

Abstract

Anti-dsDNA B cells are actively tolerized in nonautoimmune BALB/c mice, as manifested by their developmental arrest, follicular exclusion, and rapid turnover rate. Previously, we have documented changes in the maturation status and follicular localization of anti-dsDNA B cells in autoimmune-prone MRL (+/+ and lpr/lpr) mice. To determine whether these differences in developmental status and follicular localization affect the functional capacity of anti-dsDNA B cells, we have now compared their in vivo life spans and their responses to in vitro stimuli. Our study shows that although anti-dsDNA B cells from both BALB/c and MRL-+/+ mice are localized to the T/B interface, only those in BALB/c mice have a rapid turnover rate. Therefore, the immature status and not the exclusion from the B cell follicle correlates with a shortened life span. Interestingly, apoptotic anti-dsDNA B cells were not detected at the T/B interface in BALB/c mice, suggesting that they are not dying there. This study also demonstrates that anti-dsDNA B cells, regardless of maturation status or follicular localization, are able to proliferate and up-regulate the costimulatory molecule B7-2 in response to CD40 ligand and IL-4. Therefore, one of the critical in vivo differences between anti-dsDNA B cells in BALB/c and MRL-+/+ mice compared with MRL-lpr/lpr mice may be the availability of T cell help.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10640726     DOI: 10.4049/jimmunol.164.3.1161

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Cellular competition independent of BAFF/B lymphocyte stimulator results in low frequency of an autoreactive clonotype in mature polyclonal B cell compartments.

Authors:  Neda Nikbakht; Thi-Sau Migone; Chris P Ward; Tim Manser
Journal:  J Immunol       Date:  2011-06-01       Impact factor: 5.422

Review 2.  The regulation and activation potential of autoreactive B cells.

Authors:  Michele L Fields; Su-Jean Seo; Simone A Nish; Jeff H Tsai; Andrew J Caton; Jan Erikson
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

3.  In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis.

Authors:  Anthony Chang; Scott G Henderson; Daniel Brandt; Ni Liu; Riteesha Guttikonda; Christine Hsieh; Natasha Kaverina; Tammy O Utset; Shane M Meehan; Richard J Quigg; Eric Meffre; Marcus R Clark
Journal:  J Immunol       Date:  2010-12-27       Impact factor: 5.422

4.  TLR9 promotes tolerance by restricting survival of anergic anti-DNA B cells, yet is also required for their activation.

Authors:  Kevin M Nickerson; Sean R Christensen; Jaime L Cullen; Wenzhao Meng; Eline T Luning Prak; Mark J Shlomchik
Journal:  J Immunol       Date:  2013-01-07       Impact factor: 5.422

5.  ICOS expression by effector T cells influences the ability of regulatory T cells to inhibit anti-chromatin B cell responses in recipient mice.

Authors:  Brian D Hondowicz; Amrita O Batheja; Michele H Metzgar; Andrew J Caton; Jan Erikson
Journal:  J Autoimmun       Date:  2009-12-22       Impact factor: 7.094

Review 6.  Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitis.

Authors:  Filip De Keyser; Dominique Baeten; Filip Van den Bosch; Elli Kruithof; Gust Verbruggen; Herman Mielants; Eric Veys
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 7.  Germinal centers and autoimmune disease in humans and mice.

Authors:  Anthony L DeFranco
Journal:  Immunol Cell Biol       Date:  2016-08-26       Impact factor: 5.126

8.  The regulation of autoreactive B cells during innate immune responses.

Authors:  Barbara J Vilen; Jennifer A Rutan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 9.  B-cell anergy: from transgenic models to naturally occurring anergic B cells?

Authors:  John C Cambier; Stephen B Gauld; Kevin T Merrell; Barbara J Vilen
Journal:  Nat Rev Immunol       Date:  2007-07-20       Impact factor: 53.106

10.  Influence of interleukin-2 deficiency on the generation of autoimmune B cells.

Authors:  Lucile E Wrenshall; Deandra R Smith; Elliot T Stevens; John D Miller
Journal:  J Autoimmun       Date:  2007-08-09       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.